Arbutus Biopharma Corp (ABUS) earnings · rev $14.1M
These earnings events as JSON? API free 100/dayArbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
This ABUS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABUS revenue for 2025-12-31 was $14.1M. Net income was -$33.5M. Revenue was up 128.2% from 2024-12-31 to 2025-12-31. ABUS currently screens at market cap $883.0M.
When the next ABUS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 128.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ABUS research stays on the stock page; the tape stays on the quote page.
ABUS earnings FAQ
What are ABUS's latest revenue and net income?
Latest cached Arbutus Biopharma Corp (ABUS) revenue for Dec 31, 2025 was $14.1M. Net income was -$33.5M. Statements: https://lician.com/financials/abus
What is ABUS's latest diluted EPS?
Latest cached Arbutus Biopharma Corp (ABUS) diluted EPS for Dec 31, 2025 was -$0.17.
What period does the latest ABUS earnings print cover?
The latest cached Arbutus Biopharma Corp (ABUS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ABUS revenue change from the prior cached period?
Cached Arbutus Biopharma Corp (ABUS) revenue was up 128.2% from $6.2M (Dec 31, 2024) to $14.1M (Dec 31, 2025). Statements: https://lician.com/financials/abus
Where are ABUS earnings listed?
Cached earnings facts for Arbutus Biopharma Corp (ABUS) are listed at https://lician.com/earnings/abus. Statements: https://lician.com/financials/abus
Not investment advice.